Financhill
Buy
54

CAH Quote, Financials, Valuation and Earnings

Last price:
$160.03
Seasonality move :
0.48%
Day range:
$160.20 - $161.82
52-week range:
$94.29 - $168.44
Dividend yield:
1.26%
P/E ratio:
25.13x
P/S ratio:
0.18x
P/B ratio:
--
Volume:
1.4M
Avg. volume:
2.2M
1-year change:
68.86%
Market cap:
$38.5B
Revenue:
$226.8B
EPS (TTM):
$6.41

Earnings Data

Next earnings date for CAH
Aug 12
2025
Most recent earnings per share
$2.10
Missed by $0.05
(May 1/2025)
Consensus Estimate
$2.15
(May 1/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CAH Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $59.7B -- -- $2.17 --
08/12/2025 Q2 $60.9B -- -- $2.03 --
05/01/2025 Q1 $55.3B $54.9B $2.10 $2.15 -$0.05
01/30/2025 Q4 $55B $55.3B $1.65 $1.76 -$0.11
11/01/2024 Q3 $50.8B $52.3B $1.70 $1.62 $0.08
08/14/2024 Q2 $58.6B $59.9B $0.96 $1.73 -$0.77
05/02/2024 Q1 $56.1B $54.9B $1.07 $1.95 -$0.88
02/01/2024 Q4 $56.9B $57.4B $1.50 $1.60 -$0.10
11/03/2023 Q3 $54.9B $54.7B -$0.05 $1.41 -$1.46
08/15/2023 Q2 $52.7B $53.4B -$0.25 $1.48 -$1.73
05/04/2023 Q1 $49.6B $50.5B $1.34 $1.49 -$0.15
02/02/2023 Q4 -- $51.5B -$0.50 -- --
11/04/2022 Q3 -- $49.6B $0.40 -- --
08/11/2022 Q2 -- $47.1B $0.50 -- --
05/05/2022 Q1 -- $44.8B -$5.05 -- --
02/03/2022 Q4 -- $45.5B $0.17 -- --
11/09/2021 Q3 -- $44B $0.94 -- --
08/05/2021 Q2 -- $42.6B $0.40 -- --
05/06/2021 Q1 -- $39.3B $0.40 -- --
02/05/2021 Q4 -- $41.5B $2.13 -- --
11/04/2020 Q3 -- $39.1B -$0.86 -- --
08/05/2020 Q2 -- $36.7B $2.23 -- --
05/11/2020 Q1 -- $39.2B $1.19 -- --
02/06/2020 Q4 -- $39.7B $0.75 -- --
11/07/2019 Q3 -- $37.3B -$16.65 -- --
08/08/2019 Q2 -- $37.4B $0.65 -- --
05/09/2019 Q1 -- $35.2B $0.99 -- --
02/07/2019 Q4 -- $37.7B $0.93 -- --
11/08/2018 Q3 -- $35.2B $1.94 -- --
08/06/2018 Q2 -- $35.3B -$3.76 -- --
05/03/2018 Q1 -- $33.6B $0.81 -- --
02/08/2018 Q4 -- $35.2B $3.33 -- --
11/06/2017 Q3 -- $32.6B $0.36 -- --
08/02/2017 Q2 -- $33B $0.86 -- --
05/01/2017 Q1 -- $31.8B $1.20 -- --
02/07/2017 Q4 -- $33.2B $1.02 -- --
10/31/2016 Q3 -- $32B $0.96 -- --
08/02/2016 Q2 -- $31.4B $1.02 -- --
04/28/2016 Q1 -- $30.7B $1.17 -- --
02/01/2016 Q4 -- $31.4B $0.98 -- --
11/02/2015 Q3 -- $28.1B $1.15 -- --

Cardinal Health Earnings Questions

  • How Much did Cardinal Health Generate in Revenue Last Quarter?

    Cardinal Health reported $54.9B worth of top line sales in its most recent quarter.

  • Did Cardinal Health Beat Earnings Last Quarter?

    Cardinal Health announced earnings per share of $2.10 which represents a miss of analyst forecast a $2.15 per share.

  • Is Cardinal Health Profitable?

    Cardinal Health reported $2.1B that represents $8.81 per share over the last quarter.

  • What is the Analyst Consensus for Cardinal Health EPS Next Year?

    Cardinal Health's earnings are forecast to grow from $3.45 per share to $8.20 per share next year representing an increase of 135.56%.

  • When is Cardinal Health's Earnings Date?

    Cardinal Health's next earnings date is August 12, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Can Levi Stock Double?
Can Levi Stock Double?

Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 58x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
82
SBET alert for Jul 17

SharpLink Gaming [SBET] is up 0.54% over the past day.

Buy
89
EXOD alert for Jul 17

Exodus Movement [EXOD] is down 4.77% over the past day.

Buy
60
U alert for Jul 17

Unity Software [U] is up 8.52% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock